Adjuvanted Influenza Vaccination in U.S. Nursing Homes

Clinical trial NCT02882100 · COMPLETED

Trial details

NCT number: NCT02882100
Sponsor: Insight Therapeutics, LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza Influenza-like Illness

Start date: 2016-04-01
Primary completion: 2018-10-04
Enrollment: 823

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.